rs41281674
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000123.4(ERCC5):āc.2877A>Cā(p.Arg959Ser) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000627 in 1,614,174 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0034 ( 3 hom., cov: 32)
Exomes š: 0.00034 ( 1 hom. )
Consequence
ERCC5
NM_000123.4 missense, splice_region
NM_000123.4 missense, splice_region
Scores
2
9
6
Clinical Significance
Conservation
PhyloP100: 3.91
Genes affected
ERCC5 (HGNC:3437): (ERCC excision repair 5, endonuclease) This gene encodes a single-strand specific DNA endonuclease that makes the 3' incision in DNA excision repair following UV-induced damage. The protein may also function in other cellular processes, including RNA polymerase II transcription, and transcription-coupled DNA repair. Mutations in this gene cause xeroderma pigmentosum complementation group G (XP-G), which is also referred to as xeroderma pigmentosum VII (XP7), a skin disorder characterized by hypersensitivity to UV light and increased susceptibility for skin cancer development following UV exposure. Some patients also develop Cockayne syndrome, which is characterized by severe growth defects, cognitive disability, and cachexia. Read-through transcription exists between this gene and the neighboring upstream BIVM (basic, immunoglobulin-like variable motif containing) gene. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.010380447).
BP6
Variant 13-102872396-A-C is Benign according to our data. Variant chr13-102872396-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 134164.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00341 (519/152308) while in subpopulation AFR AF= 0.0118 (492/41578). AF 95% confidence interval is 0.011. There are 3 homozygotes in gnomad4. There are 237 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERCC5 | NM_000123.4 | c.2877A>C | p.Arg959Ser | missense_variant, splice_region_variant | 13/15 | ENST00000652225.2 | NP_000114.3 | |
BIVM-ERCC5 | NM_001204425.2 | c.4239A>C | p.Arg1413Ser | missense_variant, splice_region_variant | 21/23 | NP_001191354.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERCC5 | ENST00000652225.2 | c.2877A>C | p.Arg959Ser | missense_variant, splice_region_variant | 13/15 | NM_000123.4 | ENSP00000498881 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00342 AC: 521AN: 152190Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
521
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00103 AC: 258AN: 251364Hom.: 0 AF XY: 0.000846 AC XY: 115AN XY: 135870
GnomAD3 exomes
AF:
AC:
258
AN:
251364
Hom.:
AF XY:
AC XY:
115
AN XY:
135870
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000337 AC: 493AN: 1461866Hom.: 1 Cov.: 31 AF XY: 0.000305 AC XY: 222AN XY: 727230
GnomAD4 exome
AF:
AC:
493
AN:
1461866
Hom.:
Cov.:
31
AF XY:
AC XY:
222
AN XY:
727230
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00341 AC: 519AN: 152308Hom.: 3 Cov.: 32 AF XY: 0.00318 AC XY: 237AN XY: 74474
GnomAD4 genome
AF:
AC:
519
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
237
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
48
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
150
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:2
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The ERCC5 p.Arg959Ser variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs41281674) and ClinVar (classification not provided, submitted by ITMI). The variant was identified in control databases in 360 of 282766 chromosomes (1 homozygous) at a frequency of 0.001273 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: African in 317 of 24960 chromosomes (freq: 0.0127), Other in 7 of 7222 chromosomes (freq: 0.000969), Latino in 30 of 35422 chromosomes (freq: 0.000847), European (Finnish) in 1 of 25122 chromosomes (freq: 0.00004) and European (non-Finnish) in 5 of 129120 chromosomes (freq: 0.000039), but was not observed in the Ashkenazi Jewish, East Asian and South Asian populations. The p.Arg959 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The p.Arg959Ser variant occurs in the third last base of the exon. This position has been shown to be part of the splicing consensus sequence and variants involving this position sometimes affect splicing. However, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 24, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
.;.;.;D;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;.;T;T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
.;.;.;M;.
MutationTaster
Benign
D;D
PROVEAN
Pathogenic
.;.;.;D;D
REVEL
Uncertain
Sift
Uncertain
.;.;.;D;D
Sift4G
Uncertain
.;.;.;D;D
Polyphen
0.26
.;.;.;B;.
Vest4
0.76, 0.79
MutPred
0.59
.;.;.;Gain of catalytic residue at R964 (P = 0.001);.;
MVP
0.90
MPC
0.15
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at